Literature DB >> 12588714

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Henry M Blumberg, William J Burman, Richard E Chaisson, Charles L Daley, Sue C Etkind, Lloyd N Friedman, Paula Fujiwara, Malgosia Grzemska, Philip C Hopewell, Michael D Iseman, Robert M Jasmer, Venkatarama Koppaka, Richard I Menzies, Richard J O'Brien, Randall R Reves, Lee B Reichman, Patricia M Simone, Jeffrey R Starke, Andrew A Vernon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12588714     DOI： 10.1164/rccm.167.4.603

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  488 in total

1.  Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis.

Authors:  Ian M Rosenthal; Rokeya Tasneen; Charles A Peloquin; Ming Zhang; Deepak Almeida; Khisimuzi E Mdluli; Petros C Karakousis; Jacques H Grosset; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.

Authors:  Prakash M Jeena; William R Bishai; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

3.  Treatment of chronic infections with rifamycins: is resistance likely to follow?

Authors:  Richard E Chaisson
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

4.  Miliary tuberculosis after infliximab therapy in Lebanon.

Authors:  Imad Uthman; Nadim Kanj; Jinane El-Sayad; Abdul-Rahman Bizri
Journal:  Clin Rheumatol       Date:  2004-04-16       Impact factor: 2.980

Review 5.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

6.  Therapeutic drug monitoring in the treatment of active tuberculosis.

Authors:  Aylin Babalik; Aylin Babalik; Sharyn Mannix; Denis Francis; Dick Menzies
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

7.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

8.  Outcomes of multidrug-resistant tuberculosis among binational cases in El Paso, Texas.

Authors:  Gustavo Ferrer; Carlos Acuna-Villaorduna; Miguel Escobedo; Esteban Vlasich; Manuel Rivera
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

9.  Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

Authors:  W P Drake; B W Richmond; K Oswald-Richter; C Yu; J M Isom; J A Worrell; G R Shipley
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2013-11-25       Impact factor: 0.670

Review 10.  [Tuberculosis-current therapeutic principles].

Authors:  U Greinert; P Zabel
Journal:  Internist (Berl)       Date:  2003-11       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.